glutathione alkylating agents Alkylating Agents - Pharmacology of
Description
Funding This work was supported by the start-up funds for research from China Medical University (110/1210616002)
Res., 37:487-493
Knockdown of MT3 in BMM inhibited osteoclast formation and significantly decreased the total osteoclast number and spreading area (Fig
By increasing glycine levels in the synaptic cleft, GlyT1 inhibitors may improve cognitive function and negative symptoms, offering an alternative or adjunct to existing antipsychotic treatments that have limited efficacy in these domains
About this article Cite this article Omidkhoda, S.F., Rajabian, F
In the last years, several preclinical studies and clinical trials have been effectuated using different GSK-3 inhibitors, actually with few encouraging results
